The OSA approval was fairly recent, and there's reason to believe this medication's approved use cases could continue to expand
Head-to-head clinical data from the SURMOUNT-5 trial found tirzepatide produced approximately 20% greater weight loss than semaglutide at comparable doses
It was originally approved for the treatment of type 2 diabetes by the FDA in May 2022 under the brand name Mounjaro, and then, in response to the significant weight loss results during clinical trials, the FDA approved tirzepatide in November 2023 for chronic weight management under the name Zepbound
Pacek, L
As you can see, the conditions that would send you away from Henry are pretty specific, but alternatives certainly exist if you find these apply to you
Yes, Craft Concierge provides comprehensive weight management services in both Tampa and Tulsa, with both locations offering access to fellowship-trained obesity medicine expertise, comprehensive metabolic testing, GLP-1 medication prescriptions, and quarterly monitoring through direct primary care membership